These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 24680249)
1. Risk markers for coronary plaque progression and destabilization beyond LDL-cholesterol in acute coronary syndrome. Taguchi I; Koizumi S; Kageyama M; Nasuno T; Toyoda S; Abe S; Node K; Inoue T Int J Cardiol; 2014 May; 173(2):329-31. PubMed ID: 24680249 [No Abstract] [Full Text] [Related]
2. Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: a pilot study. Kato S; Endo I; Fujimura M; Kuriwaka-Kido R; Fujinaka Y; Aihara K; Iwase T; Inoue D; Akaike M; Abe M; Matsumoto T Atherosclerosis; 2013 Jul; 229(1):182-5. PubMed ID: 23639859 [TBL] [Abstract][Full Text] [Related]
3. Lipid profile and non-enzymic antioxidant status in patients with acute coronary syndrome in South India. Gururajan P; Gurumurthy P; Nayar P; Chockalingam M; Bhuvaneshwari S; Babu S; Sarasabharati A; Victor D; Cherian KM Heart Lung Circ; 2010 Feb; 19(2):75-80. PubMed ID: 19914867 [TBL] [Abstract][Full Text] [Related]
4. LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk. Ofori-Asenso R; Zoungas S; Tonkin A; Liew D Clin Pharmacol Ther; 2018 Aug; 104(2):235-238. PubMed ID: 30004113 [No Abstract] [Full Text] [Related]
5. Letter by Schindhelm regarding article, "High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study". Schindhelm RK Circulation; 2011 Jul; 124(4):e143; author reply e144. PubMed ID: 21788597 [No Abstract] [Full Text] [Related]
6. Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study). Kelly CR; Weisz G; Maehara A; Mintz GS; Mehran R; Lansky AJ; Parise H; de Bruyne B; Serruys PW; Stone GW Am J Cardiol; 2014 Aug; 114(3):376-83. PubMed ID: 24931291 [TBL] [Abstract][Full Text] [Related]
7. LDL-Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome. Field PA; Vasan RS Clin Pharmacol Ther; 2018 Aug; 104(2):232-234. PubMed ID: 30004115 [TBL] [Abstract][Full Text] [Related]
9. Effect of age on atherogenicity of LDL and inflammatory markers in healthy women. Paik JK; Chae JS; Kang R; Kwon N; Lee SH; Lee JH Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):967-72. PubMed ID: 23021775 [TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Kojima S; Kojima S; Maruyoshi H; Nagayoshi Y; Kaikita K; Sumida H; Sugiyama S; Funahashi T; Ogawa H Int J Cardiol; 2011 Mar; 147(3):371-6. PubMed ID: 19896734 [TBL] [Abstract][Full Text] [Related]
11. Plasma lipidomic analysis of stable and unstable coronary artery disease. Meikle PJ; Wong G; Tsorotes D; Barlow CK; Weir JM; Christopher MJ; MacIntosh GL; Goudey B; Stern L; Kowalczyk A; Haviv I; White AJ; Dart AM; Duffy SJ; Jennings GL; Kingwell BA Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2723-32. PubMed ID: 21903946 [TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]
13. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks]. Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206 [TBL] [Abstract][Full Text] [Related]
14. Differential protein biomarker expression and their time-course in patients with a spectrum of stable and unstable coronary syndromes in the Integrated Biomarker and Imaging Study-1 (IBIS-1). Wykrzykowska JJ; Garcia-Garcia HM; Goedhart D; Zalewski A; Serruys PW Int J Cardiol; 2011 May; 149(1):10-6. PubMed ID: 20060182 [TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Al-Benna S; Hamilton CA; McClure JD; Rogers PN; Berg GA; Ford I; Delles C; Dominiczak AF Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):218-23. PubMed ID: 16254199 [TBL] [Abstract][Full Text] [Related]
17. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. Chhatriwalla AK; Nicholls SJ; Wang TH; Wolski K; Sipahi I; Crowe T; Schoenhagen P; Kapadia S; Tuzcu EM; Nissen SE J Am Coll Cardiol; 2009 Mar; 53(13):1110-5. PubMed ID: 19324254 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients. Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Kalboussi N; Ben Rejeb N; Nabli N; Ben Abdelaziz A; Boughazala E; Bouslama A Metab Syndr Relat Disord; 2010 Dec; 8(6):515-22. PubMed ID: 20715933 [TBL] [Abstract][Full Text] [Related]
19. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy. Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704 [TBL] [Abstract][Full Text] [Related]
20. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome]. Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]